“Steven D. Rubin”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  3/29/24  as  ↓Signatory

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Steven D. Rubin” has been a Group Member with  3  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
6/9/21		FL	Frost Phillip MD et al	1	SC 13D/A	WA	Cocrystal Pharma, Inc.
11/19/20		FL	Opko Health, Inc.	4	SC 13D/A	WA	Cocrystal Pharma, Inc.
3/19/19		FL	Frost Gamma Investments Trust	1	SC 13D/A	WA	Cocrystal Pharma, Inc.

“Steven D. Rubin” has/had a Group Member interest in  one  Issuer:

“Steven D. Rubin” has been a Group Member with  5  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
6/9/21		FL	Frost Gamma Investments Trust	5	SC 13D/A	FL	Frost Phillip MD et al	WA	Cocrystal Pharma, Inc.
11/19/20		•	Phillip Frost, M.D.	5	SC 13D/A	FL	Opko Health, Inc.	WA	Cocrystal Pharma, Inc.
3/19/19		WA	Gary Wilcox	1	SC 13D/A	FL	Frost Gamma Investments Trust	WA	Cocrystal Pharma, Inc.
		GA	Raymond F. Schinazi	1
		•	Roger Kornberg	1

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Steven D. Rubin” has been a Signatory for/with  8  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
3/29/24		FL	Opko Health, Inc.	49	8-K	—
3/7/24		FL	Red Violet, Inc.	6	10-K	—
1/24/24		MA	Eloxx Pharmaceuticals, Inc.	7	S-3	—
6/22/23		CA	ChromaDex Corp.	1	S-8	—
5/2/22		CT	GeneDx Holdings Corp.	5	8-K	—
1/19/22		NY	Blackstone Holdings III L.P.	1	SC 13D/A	CT	GeneDx Holdings Corp.
6/9/21		FL	Frost Phillip MD et al	1	SC 13D/A	WA	Cocrystal Pharma, Inc.
5/26/20		FL	Rubin Steven D	2	4	MA	Eloxx Pharmaceuticals, Inc.

“Steven D. Rubin” has/had a Signatory interest in  3  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
4/20/23		CT	GeneDx Holdings Corp.	4	SC 13D/A	FL	Opko Health, Inc.
6/9/21		WA	Cocrystal Pharma, Inc.	2	SC 13D/A	FL	Frost Phillip MD et al
5/26/20		MA	Eloxx Pharmaceuticals, Inc.	2	4	FL	Rubin Steven D